Barclays maintains an 'Overweight' on HCA Holdings (HCA); HealthOne Transaction Should Provide a Healthy Boost to EPS
Tweet Send to a Friend
Barclays maintains an 'Overweight' on HCA Holdings (NYSE: HCA), PT $40.
Barclays analyst says, "Last night, HCA announced that it ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Last night, HCA announced that it ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
